Status:
COMPLETED
ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients
Lead Sponsor:
Duke University
Conditions:
Hematopoietic Steam Cell Transplantation (HCT)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a research study to develop and test a novel protocol to reduce physical and psychological vulnerabilities that contribute to treatment intolerance and treatment-related morbidity and mortalit...
Eligibility Criteria
Inclusion
- Patient:
- Over the age of 18
- Undergoing allogeneic HCT for any cancer or noncancer illness
- English speaking
- Has a caregiver willing to participate
- Caregiver:
- Over the age of 18
- English speaking
Exclusion
- Under the age of 18
- Non-English speaking
- Has a caregiver unwilling to participate
Key Trial Info
Start Date :
October 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04423939
Start Date
October 14 2020
End Date
February 1 2025
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lauren Hill
Raleigh, North Carolina, United States, 27608